Abciximab as an adjunctive therapy for patients undergoing percutaneous coronary interventions

By Parikh Devang   Juergens Craig P  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 2, 2011-02 ,pp. : 235-246

Informa Healthcare

Access to resources Recommend Favorite

Restenosis and gene therapy

By Quarck R.   Holvoet P.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 1, 2001-01 ,pp. : 79-91

Informa Healthcare

Access to resources Recommend Favorite

Soluble fms-like tyrosine kinase-1 (sFLT-1) predicts post-percutaneous coronary intervention (PCI) myocardial infarction (MI type 4a)

By Searle Julia   Slagman Anna   Gwosc Stefanie   Vollert Jörn Ole   Holert Fabian   Müller Christian   Muller Reinhold   Möckel Martin  

Biomarkers, Vol. 17, Iss. 8, 2012-12 ,pp. : 730-737

Informa Healthcare

Access to resources Recommend Favorite

Increases in serum concentration of human heart-type fatty acid-binding protein following elective coronary intervention

By Sbarouni Eftihia   Georgiadou Panagiota   Sklavainas Ioannis   Chaidaroglou Antigoni   Panagiotakos Demosthenes   Degiannis Demitrios   Voudris Vassilis  

Biomarkers, Vol. 14, Iss. 5, 2009-08 ,pp. : 317-320

Informa Healthcare

Access to resources Recommend Favorite

Dynamic changes in serum angiopoietin-1, angiopoietin-2, and angiopoietin-2/angiopoietin-1 ratio in acute myocardial infarction patients treated with primary percutaneous coronary intervention

By Chen Shaomin   Guo Lijun   Cui Ming   Sun Lijie   Mi Lin  

Biomarkers, Vol. 17, Iss. 5, 2012-08 ,pp. : 441-446

Informa Healthcare

Access to resources Recommend Favorite